
DOI . ORG {
}
Title[redir]:
Hsp90 inhibitor NMS-E973 exerts the anticancer effect against glioblas | OTT
Description:
Hsp90 inhibitor NMS-E973 exerts the anticancer effect against glioblastoma via induction of PUMA-mediated apoptosis Libo Sun,1 Shoujun Yang,2 Guonan Chi,1 Xingyi Jin1 1First Department of Neurosurgery, China-Japan Union Hospital of Jilin University, Changhun, Jilin, Peopleβs Republic of China; 2Department of Rehabilitation, China-Japan Union Hospital of Jilin University, Changhun, Jilin, Peopleβs Republic of China Background: Glioblastoma is one of the most aggressive and common malignancies of the central nervous system in humans. Owing to the correlation of high Hsp90 expression with prognosis and clinical pathology features of diverse types of cancer, targeting Hsp90 with small-molecule inhibitors has become a promising anticancer strategy.Purpose: In this study, we aimed to explore the possibility of anticancer effect of NMS-E973 in giloblastoma and elucidate the mechanism.Methods: Cell based MTT assay and colony formation assay were used to detect cell viability. Apoptosis was analyzed by nuclear staining with Hoechst 33258 and Annexin V/propidium iodide staining followed by flow cytometry. Western-blot and RT-PCR were used to detect gene expression. Xenograft assay was used to explore the anticancer effect of NMS-E973 in vivo.Results: We found that NMS-E973 induces apoptosis and inhibits cell growth in glioblastoma cells in cell culture and xenograft models. As a proapoptotic Bcl-2 member, PUMA was induced by NMS-E973 in a p53-dependent manner in glioblastoma in cell culture, thereby inducing apoptosis in glioblastoma cells. Furthermore, PUMA was induced by NMS-E973 treatment in xenograft tumors, and deficiency in PUMA significantly suppressed the antitumor effects of NMS-E973.Conclusion: Our study suggests that PUMA-mediated apoptosis is important for the therapeutic responses of NMS-E973. Induction of PUMA might be a potential biomarker for predicting NMS-E973 responses. Keywords: NMS-E973, PUMA, glioblastoma, apoptosis
Matching Content Categories {π}
- Social Networks
- Science
- Education
Content Management System {π}
What CMS is doi.org built with?
Custom-built
No common CMS systems were detected on Doi.org, and no known web development framework was identified.
Traffic Estimate {π}
What is the average monthly size of doi.org audience?
ποΈ Massive Traffic: 50M - 100M visitors per month
Based on our best estimate, this website will receive around 75,586,609 visitors per month in the current month.
check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush
How Does Doi.org Make Money? {πΈ}
We can't figure out the monetization strategy.
Not all websites focus on profit; some are designed to educate, connect people, or share useful tools. People create websites for numerous reasons. And this could be one such example. Doi.org might have a hidden revenue stream, but it's not something we can detect.
Keywords {π}
article, press, medical, dove, published, work, authors, retracted, images, author, open, learn, download, terms, informa, reprints, access, journals, peer, review, permission, publication, editor, figure, plc, contact, testimonials, favored, login, scientific, research, editorial, policies, guidelines, papers, manuscript, journal, oncotargets, therapy, volume, original, hsp, nmse, apoptosis, sun, yang, chi, jin, pdf, supplementary,
Topics {βοΈ}
editorial policies including fast-track processing dove medical press manuscript login favored authors cope guidelines offer real benefits onco targets ther mol cancer ther academic publishing division london sw1p 1wg uk vat group specific author published article papers review informa plc nms-e973 articles published author medical journals retracted article published work unrelated article editor requested satisfactory explanation approved publication full terms published journals Β» oncotargets scientific journal alerts pharmaceutical industry anticancer effect s160813 checked journal oncotargets scholarly record decision-making remain online digitally watermarked properly attributed opinions expressed necessarily reflect rights reserved site 5 howick place figure 6e figure 6c editor article
Questions {β}
- Why publish with us?
Social Networks {π}(9)
- https://www.facebook.com/DoveMedicalPress
- https://twitter.com/DovePress
- https://www.linkedin.com/company/dove-medical-press
- https://www.youtube.com/user/dovepress
- https://www.instagram.com/dovemedicalpress/
- https://twitter.com/intent/tweet?text=Hsp90+inhibitor+NMS-E973+exerts+the+anticancer+effect+against+glioblas+%7C+OTT+%40DovePress&related=DovePress&url=https://www.dovepress.com/hsp90-inhibitor-nms-e973-exerts-the-anticancer-effect-against-glioblas-peer-reviewed-fulltext-article-OTT
- https://www.facebook.com/sharer.php?u=https://www.dovepress.com/hsp90-inhibitor-nms-e973-exerts-the-anticancer-effect-against-glioblas-peer-reviewed-fulltext-article-OTT&t=Hsp90 inhibitor NMS-E973 exerts the anticancer effect against glioblas | OTT
- https://www.linkedin.com/shareArticle?mini=true&url=https://www.dovepress.com/hsp90-inhibitor-nms-e973-exerts-the-anticancer-effect-against-glioblas-peer-reviewed-fulltext-article-OTT&title=Hsp90 inhibitor NMS-E973 exerts the anticancer effect against glioblas | OTT&source=Dove Press
- https://www.reddit.com/submit?url=https://www.dovepress.com/hsp90-inhibitor-nms-e973-exerts-the-anticancer-effect-against-glioblas-peer-reviewed-fulltext-article-OTT
External Links {π}(54)
- Get to know https://www.dovepress.com/hsp90-inhibitor-nms-e973-exerts-the-anticancer-effect-against-glioblas-peer-reviewed-fulltext-article-OTT/browse_journals.php's earnings
- Get to know https://www.dovepress.com/hsp90-inhibitor-nms-e973-exerts-the-anticancer-effect-against-glioblas-peer-reviewed-fulltext-article-OTT/about-us's earnings
- Check the income stats for https://www.dovepress.com/hsp90-inhibitor-nms-e973-exerts-the-anticancer-effect-against-glioblas-peer-reviewed-fulltext-article-OTT/editorial-policies
- Income figures for https://www.dovepress.com/hsp90-inhibitor-nms-e973-exerts-the-anticancer-effect-against-glioblas-peer-reviewed-fulltext-article-OTT/author-guidelines
- How much does https://www.dovepress.com/hsp90-inhibitor-nms-e973-exerts-the-anticancer-effect-against-glioblas-peer-reviewed-fulltext-article-OTT/peer-review-guidelines pull in?
- How much profit is https://www.dovepress.com/hsp90-inhibitor-nms-e973-exerts-the-anticancer-effect-against-glioblas-peer-reviewed-fulltext-article-OTT/open_outlook.php making per month?
- https://www.dovepress.com/hsp90-inhibitor-nms-e973-exerts-the-anticancer-effect-against-glioblas-peer-reviewed-fulltext-article-OTT/browse_hot_topics.php's total income per month
- How much does https://www.dovepress.com/hsp90-inhibitor-nms-e973-exerts-the-anticancer-effect-against-glioblas-peer-reviewed-fulltext-article-OTT/podcasts pull in?
- How much does https://www.dovepress.com/hsp90-inhibitor-nms-e973-exerts-the-anticancer-effect-against-glioblas-peer-reviewed-fulltext-article-OTT/blog pull in?
- What's the financial outcome of https://www.dovepress.com/hsp90-inhibitor-nms-e973-exerts-the-anticancer-effect-against-glioblas-peer-reviewed-fulltext-article-OTT/bulk_reprints.php?
- How much revenue does https://www.dovepress.com/hsp90-inhibitor-nms-e973-exerts-the-anticancer-effect-against-glioblas-peer-reviewed-fulltext-article-OTT/submit_step_1.php produce monthly?
- What's the total monthly financial gain of https://www.dovepress.com/hsp90-inhibitor-nms-e973-exerts-the-anticancer-effect-against-glioblas-peer-reviewed-fulltext-article-OTT/#?
- Financial intake of https://www.dovepress.com/hsp90-inhibitor-nms-e973-exerts-the-anticancer-effect-against-glioblas-peer-reviewed-fulltext-article-OTT/contact
- How much money does https://www.dovepress.com/hsp90-inhibitor-nms-e973-exerts-the-anticancer-effect-against-glioblas-peer-reviewed-fulltext-article-OTT/sustainability.php generate?
- What's https://www.dovepress.com/hsp90-inhibitor-nms-e973-exerts-the-anticancer-effect-against-glioblas-peer-reviewed-fulltext-article-OTT/press-releases's gross income?
- Revenue of https://www.dovepress.com/hsp90-inhibitor-nms-e973-exerts-the-anticancer-effect-against-glioblas-peer-reviewed-fulltext-article-OTT/why-publish-with-dove-press/testimonials
- Discover the revenue of https://www.dovepress.com/hsp90-inhibitor-nms-e973-exerts-the-anticancer-effect-against-glioblas-peer-reviewed-fulltext-article-OTT/why-publish-with-dove-press/favored-authors
- https://www.dovepress.com/hsp90-inhibitor-nms-e973-exerts-the-anticancer-effect-against-glioblas-peer-reviewed-fulltext-article-OTT/permissions.php's financial summary
- How much does https://www.dovepress.com/hsp90-inhibitor-nms-e973-exerts-the-anticancer-effect-against-glioblas-peer-reviewed-fulltext-article-OTT/presubmission_check.php net monthly?
- Get to know what's the income of https://www.dovepress.com/hsp90-inhibitor-nms-e973-exerts-the-anticancer-effect-against-glioblas-peer-reviewed-fulltext-article-OTT/login.php
- How profitable is http://www.dovepress.com.cn?
- How much does https://www.dovepress.com/hsp90-inhibitor-nms-e973-exerts-the-anticancer-effect-against-glioblas-peer-reviewed-fulltext-article-OTT/index.php net monthly?
- Revenue of https://www.dovepress.com/hsp90-inhibitor-nms-e973-exerts-the-anticancer-effect-against-glioblas-peer-reviewed-fulltext-article-OTT/search_advance.php
- Get to know https://www.dovepress.com/hsp90-inhibitor-nms-e973-exerts-the-anticancer-effect-against-glioblas-peer-reviewed-fulltext-article-OTT/editorial_policies.php's earnings
- What's the financial gain of https://www.dovepress.com/hsp90-inhibitor-nms-e973-exerts-the-anticancer-effect-against-glioblas-peer-reviewed-fulltext-article-OTT/script_status.php?
- How much does https://www.dovepress.com/hsp90-inhibitor-nms-e973-exerts-the-anticancer-effect-against-glioblas-peer-reviewed-fulltext-article-OTT/register.php pull in monthly?
- How much money does https://www.dovepress.com/about_dovepress.php generate?
- What's the revenue for https://www.dovepress.com/why-publish-with-dove-press/open-access/?
- How much does https://www.dovepress.com/hsp90-inhibitor-nms-e973-exerts-the-anticancer-effect-against-glioblas-peer-reviewed-fulltext-article-OTT/fav_author.php make?
- What's https://www.dovepress.com/hsp90-inhibitor-nms-e973-exerts-the-anticancer-effect-against-glioblas-peer-reviewed-fulltext-article-OTT/oncotargets-and-therapy-journal's gross income?
- How profitable is https://www.dovepress.com/hsp90-inhibitor-nms-e973-exerts-the-anticancer-effect-against-glioblas-peer-reviewed-fulltext-article-OTT/oncotargets-and-therapy-archive23-v1272?
- Find out how much https://www.dovepress.com/hsp90-inhibitor-nms-e973-exerts-the-anticancer-effect-against-glioblas-peer-reviewed-fulltext-article-OTT/qr.php?p=https://www.dovepress.com/hsp90-inhibitor-nms-e973-exerts-the-anticancer-effect-against-glioblas-peer-reviewed-fulltext-article-OTT earns monthly
- What's the monthly income of https://www.dovepress.com/hsp90-inhibitor-nms-e973-exerts-the-anticancer-effect-against-glioblas-peer-reviewed-fulltext-article-OTT/mailto:?subject=Open Access article on Dove Medical Press&body=Check out this article: https://www.dovepress.com/hsp90-inhibitor-nms-e973-exerts-the-anticancer-effect-against-glioblas-peer-reviewed-fulltext-article-OTT?
- What's the financial outcome of https://www.dovepress.com/hsp90-inhibitor-nms-e973-exerts-the-anticancer-effect-against-glioblas-peer-reviewed-fulltext-article-OTT/article_metric.php?article_id=37334?
- Financial intake of https://www.dovepress.com/hsp90-inhibitor-nms-e973-exerts-the-anticancer-effect-against-glioblas-peer-reviewed-fulltext-article-OTT/get_permissions.php?a_id=37334
- https://www.dovepress.com/hsp90-inhibitor-nms-e973-exerts-the-anticancer-effect-against-glioblas-peer-reviewed-fulltext-article-OTT/author_profile.php?id=911255 income
- How much cash flow does https://www.dovepress.com/hsp90-inhibitor-nms-e973-exerts-the-anticancer-effect-against-glioblas-peer-reviewed-fulltext-article-OTT/author_profile.php?id=911256 have monthly?
- How much does https://www.dovepress.com/hsp90-inhibitor-nms-e973-exerts-the-anticancer-effect-against-glioblas-peer-reviewed-fulltext-article-OTT/author_profile.php?id=911257 bring in each month?
- What's the monthly money flow for https://www.dovepress.com/hsp90-inhibitor-nms-e973-exerts-the-anticancer-effect-against-glioblas-peer-reviewed-fulltext-article-OTT/author_profile.php?id=911254?
- Get to know https://orcid.org/0000-0001-8050-525X's earnings
- What's https://www.dovepress.com/hsp90-inhibitor-nms-e973-exerts-the-anticancer-effect-against-glioblas-peer-reviewed-fulltext-article-OTT/public_profile.php?id=313379's gross income?
- What's the revenue for https://www.dovepress.com/hsp90-inhibitor-nms-e973-exerts-the-anticancer-effect-against-glioblas-peer-reviewed-fulltext-article-OTT/article/download/37334?
- How much income is https://www.dovepress.com/hsp90-inhibitor-nms-e973-exerts-the-anticancer-effect-against-glioblas-peer-reviewed-fulltext-article-OTT/article/download/37334&supplementary_filename=T1RULTE2MDgxMy1oc3A5MC1pbmhpYml0b3Itbm1zLWU5NzMtZXhlcnQtYW50aS1jYW5jZXItZWZmZWN0LWFnYWluc3QtZ2wucGRm earning monthly?
- How much does https://www.dovepress.com/retraction-hsp90-inhibitor-nms-e973-exerts-the-anticancer-effect-again-peer-reviewed-fulltext-article-OTT rake in every month?
- Learn how profitable https://www.dovepress.com/terms.php is on a monthly basis
- What's https://creativecommons.org/licenses/by-nc/3.0/'s gross income?
- Monthly income for https://www.informa.com/privacy-policy/
- What's the monthly money flow for https://www.dovepress.com/hsp90-inhibitor-nms-e973-exerts-the-anticancer-effect-against-glioblas-peer-reviewed-fulltext-article-OTT/partners.php?
- How much revenue does https://www.dovepress.com/hsp90-inhibitor-nms-e973-exerts-the-anticancer-effect-against-glioblas-peer-reviewed-fulltext-article-OTT/terms.php produce monthly?
- Profit of https://www.dovepress.com/hsp90-inhibitor-nms-e973-exerts-the-anticancer-effect-against-glioblas-peer-reviewed-fulltext-article-OTT/cookies.php
- https://www.dovepress.com/hsp90-inhibitor-nms-e973-exerts-the-anticancer-effect-against-glioblas-peer-reviewed-fulltext-article-OTT/#page-top's financial summary
- What's the revenue for https://www.dovepress.com/hsp90-inhibitor-nms-e973-exerts-the-anticancer-effect-against-glioblas-peer-reviewed-fulltext-article-OTT/privacy.php?
- Get to know what's the income of https://phplab.nz/
- Profit of https://www.adhesion.co.nz
Analytics and Tracking {π}
- Google Analytics
- Google Tag Manager
- Google Universal Analytics
Libraries {π}
- jQuery
Emails and Hosting {βοΈ}
Mail Servers:
- mx.zoho.eu
- mx2.zoho.eu
- mx3.zoho.eu
Name Servers:
- josh.ns.cloudflare.com
- zita.ns.cloudflare.com
CDN Services {π¦}
- Com/cm/ef49a3f1-d8c1-47d6-88fc-50e41130631f/airgap